Itraconazole
Is It Right for You?
A complete guide to Itraconazole — what it treats, how it works, dosages, side effects, and when a clinician may prescribe it following an online consultation.
What Is Itraconazole?
Itraconazole is an orally administered triazole antifungal agent with broad-spectrum activity against a wide range of pathogenic fungi. It is available generically and under the brand name Sporanox, supplied as 100 mg capsules and as an oral liquid solution (10 mg/ml). Itraconazole is one of the most widely used systemic antifungals in UK primary care, particularly for the treatment of dermatophyte nail infections (onychomycosis), pityriasis versicolor, oral and oesophageal candidiasis, and superficial tinea infections resistant to topical treatment.
Itraconazole is highly lipophilic and keratinophilic — it concentrates extensively in skin, nail, and hair tissue. Nail concentrations after a course of oral itraconazole exceed those in plasma by a factor of up to five times, and persist in nail keratin for months after treatment is completed, allowing pulse dosing regimens that exploit this tissue retention. Systemic bioavailability from capsules is significantly dependent on gastric acid and fat content — taking capsules with a full meal and an acidic drink (fruit juice) markedly improves absorption.
What Conditions Does Itraconazole Treat?
Itraconazole is prescribed for:
Dermatophyte infections of the skin (ringworm), feet (athlete's foot), groin (jock itch), and scalp (tinea capitis) are primarily treated topically, but itraconazole is indicated when infections are extensive, resistant to topical treatment, involve keratinised tissue heavily, or where scalp infection (tinea capitis — which requires systemic treatment) is the indication.
Pityriasis versicolor is a common superficial fungal infection of the skin caused by Malassezia species, characterised by hypo- or hyperpigmented macules on the trunk, neck, and upper arms. Itraconazole is used when topical treatment (selenium sulphide, ketoconazole shampoo) has failed or extensive disease warrants systemic therapy.
Candidal infections of the mouth (oral thrush) and oesophagus — particularly in immunocompromised patients (HIV, cancer chemotherapy, long-term systemic corticosteroids) — are treated with itraconazole oral solution, which also provides topical contact activity in the oral mucosa in addition to systemic absorption.
While Itraconazole is effective for managing fungal infections, it should be used cautiously in patients with a history of hypersensitivity or heart failure.
How Does Itraconazole Work?
Itraconazole inhibits the fungal enzyme lanosterol 14-alpha-demethylase (CYP51), a cytochrome P450 enzyme essential for the biosynthesis of ergosterol — the primary sterol component of the fungal cell membrane, analogous to cholesterol in mammalian cell membranes. By blocking ergosterol synthesis, itraconazole depletes ergosterol from the fungal cell membrane, causing accumulation of toxic methylated sterols, disruption of membrane structure and function, impaired membrane fluidity, leakage of cellular contents, and ultimately fungistatic (and at higher concentrations, fungicidal) activity.
Itraconazole has significantly greater affinity for fungal CYP51 than for mammalian cytochrome P450 enzymes — the basis of its selective antifungal activity. However, it does inhibit human CYP enzymes (particularly CYP3A4) to a clinically significant degree, which is the source of its extensive and important drug interactions.
Dosages & Administration
The correct dose depends on the type and severity of infection, age, weight, and kidney function. Always follow your clinician's instructions. The table below is for general reference only.
Administration Tips
Itraconazole capsules must be taken immediately after a full meal and, ideally, with an acidic drink such as orange juice or a cola beverage. Gastric acid is required to dissolve the capsule contents and enable absorption; the post-meal gastric acid environment dramatically improves bioavailability. Taking capsules on an empty stomach or with PPI co-medication reduces absorption significantly and may result in treatment failure.
The oral solution (for candidiasis and patients unable to swallow capsules) should be taken on an empty stomach, swirled around the mouth before swallowing, to maximise both topical oral contact and systemic absorption. The solution formulation has better bioavailability than capsules and does not require food.
Side Effects of Itraconazole
Itraconazole is generally well tolerated, but some side effects may occur.
- Nausea, abdominal discomfort, vomiting, diarrhoea: GI side effects are the most commonly reported; usually mild and transient. Taking with food (as required for capsule absorption) reduces this.
- Headache, dizziness
- Elevated liver enzymes: Usually transient and asymptomatic; clinically significant hepatotoxicity is uncommon at standard doses but has been reported.
- Skin rash or urticaria
- Hepatotoxicity: Clinically significant liver injury, including rare cases of acute hepatic failure and death. Risk is higher with prolonged courses. Liver function tests should be checked if symptoms of hepatotoxicity develop (jaundice, dark urine, persistent nausea, abdominal pain, fatigue).
- Heart failure: Itraconazole has a negative inotropic effect and is contraindicated in patients with evidence of ventricular dysfunction. New or worsening dyspnoea, oedema, or breathlessness during treatment should prompt immediate medical review.
- Stevens-Johnson syndrome / toxic epidermal necrolysis: Very rare hypersensitivity reactions.
- Peripheral neuropathy: Predominantly with prolonged courses.
Patients should be informed about the risk of hepatotoxicity and the importance of monitoring liver function during treatment.
Drug Interactions
Inform your clinician about all medications you are taking, as itraconazole is a potent inhibitor of CYP3A4 and may interact with various drugs.
Itraconazole strongly inhibits CYP3A4, significantly increasing statin levels and risk of severe myopathy or rhabdomyolysis. Avoid concurrent use, especially with simvastatin and lovastatin.
May increase anticoagulant plasma levels, significantly increasing bleeding risk. Monitor closely and adjust therapy as necessary.
Increased sedative effects due to reduced metabolism may lead to excessive sedation or respiratory depression. Avoid concurrent use where possible.
Increased drug levels may lead to QT prolongation and serious cardiac arrhythmias. Avoid combination where possible.
Important Warnings
Itraconazole is one of the most potent CYP3A4 inhibitors available. Before prescribing, a thorough review of all current medications — including OTC preparations, herbal remedies, and supplements — is mandatory. Potentially fatal interactions exist with statins, anticoagulants, immunosuppressants, antiarrhythmics, and sedative drugs.
Itraconazole has a negative inotropic effect. It should not be used in patients with heart failure or evidence of ventricular dysfunction. New breathlessness, ankle swelling, or worsening exercise tolerance during treatment should prompt immediate medical review and discontinuation.
Failing to take itraconazole capsules immediately after a full meal significantly reduces absorption and risks treatment failure, particularly for nail infections. Fruit juice or cola (not water or milk) should be taken with the capsules.
Do not use itraconazole during pregnancy. Use effective contraception during and for 2 months after treatment.
Speak to a Clinician About Treatment
Getting advice no longer means sitting in a waiting room. Through The GP Service, you can consult with a licensed clinician in minutes — from home, on your lunch break, or wherever works for you. If treatment is clinically appropriate, your clinician can issue a prescription during the consultation. A consultation does not guarantee a prescription.
The treatment you need, when you need it.
Itraconazole FAQs
Itraconazole achieves mycological cure (elimination of the fungus) typically within 3 months of completing a pulse course or 3–4 months of continuous treatment. However, clinical cure — the appearance of a visibly healthy, clear nail — takes much longer because nails grow slowly (approximately 1 mm per month for toenails). Full toenail replacement takes 9–18 months, meaning a normal-looking nail will not be apparent until months after the fungus has been eradicated. Patients should be counselled that the nail will gradually grow out and improve progressively.
Both regimens are effective for toenail onychomycosis. Pulse therapy (200 mg twice daily for one week per month for three months) exploits the fact that itraconazole persists in nail tissue for months after each pulse, achieving sustained therapeutic nail concentrations with less drug overall. Continuous therapy (200 mg once daily for 12 weeks) provides constant daily dosing. Both approaches have similar cure rates; pulse dosing uses less drug, may have lower side effect burden, and can be more convenient for some patients.
Ibuprofen is not significantly metabolised by CYP3A4 and does not have a clinically important pharmacokinetic interaction with itraconazole. Standard doses of ibuprofen can generally be used alongside itraconazole. However, always inform your clinician of all medications when being prescribed itraconazole, as many other drugs do interact significantly.
This depends on which statin you take. Simvastatin and lovastatin are absolutely contraindicated with itraconazole — the combination can cause severe rhabdomyolysis (muscle breakdown). Atorvastatin levels are also significantly increased and its use with itraconazole should be avoided or managed with a reduced dose under specialist supervision. Rosuvastatin and pravastatin are not primarily CYP3A4-metabolised and are safer alternatives during itraconazole courses. Always inform your prescribing clinician about statin use before itraconazole is initiated.